1.Six cases of occupational acute 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride poisoning.
Qian ZHOU ; Xiang-dong JIAN ; Wei ZHANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2011;29(5):348-348
Adult
;
Carbodiimides
;
poisoning
;
Humans
;
Male
;
Methylamines
;
poisoning
;
Occupational Exposure
;
Young Adult
5.A case report of Kearns-Sayre syndrome.
Wei-hua ZHANG ; Qian TONG ; Dong-mei CHEN
Chinese Journal of Cardiology 2011;39(4):369-369
6.Leukemia with hepatosplenic fungal disease: two cases report and literature review.
Qian WANG ; Xu-dong WEI ; Qing-song YIN
Chinese Journal of Hematology 2011;32(10):699-700
Adult
;
Female
;
Humans
;
Leukemia
;
complications
;
microbiology
;
Liver
;
microbiology
;
Male
;
Mycoses
;
complications
;
Spleen
;
microbiology
;
Young Adult
7.Correlation Between Outpatient's Medical Knowledge and Satisfaction Degree
Guiyang LIU ; Yuning WEI ; Shenghui DONG ; Qian CAO ; Jing ZHANG ;
Chinese Journal of Pharmacoepidemiology 2006;0(01):-
Objective:To investigate outpatient's medicine knowledge and satisfaction degree and analyze their correlation.Method:150 outpatients,their doctors and pharmacists were investigated with a fieldwork method.Patients' medical knowledge and satisfaction degree were measured with a quantitative scale table,and their correlation was calculat- ed with a linear regression method.Result:Almost all the doctors and pharmacists could provide their patients with their guidance about medicines,which focused on drug dosage and taking ways.Fewer than 20% patients could take medical ad- vice of potential risks and notice of taking medicine.A significant correlation was shown between patient's medical knowl- edge and satisfaction degree(r=0.76).Conclusion:More guidance from doctors and pharmacists should be provided for outpatients.The medical knowledge learned by patients could influence patient's satisfaction degree significantly.
8.Clinical characterization of 61 cases of diffuse large B-cell lymphoma with different prognosis.
Qian WANG ; Xu-Dong WEI ; Qing-Song YIN
Chinese Journal of Oncology 2012;34(2):136-137
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Cyclophosphamide
;
therapeutic use
;
DNA-Binding Proteins
;
metabolism
;
Doxorubicin
;
therapeutic use
;
Female
;
Germinal Center
;
pathology
;
Humans
;
Immunohistochemistry
;
Interferon Regulatory Factors
;
metabolism
;
Lymphoma, Large B-Cell, Diffuse
;
classification
;
drug therapy
;
metabolism
;
pathology
;
Male
;
Middle Aged
;
Neprilysin
;
metabolism
;
Prednisone
;
therapeutic use
;
Prognosis
;
Proto-Oncogene Proteins c-bcl-6
;
Vincristine
;
therapeutic use
9.Clinical features of ten cases of cryptogenic multifocal ulcerous stenosing enteritis
Dong WU ; Dan CHEN ; Wei LIU ; Weixun ZHOU ; Jiaming QIAN
Chinese Journal of Digestion 2017;37(2):79-83
Objective To investigate the clinical features of cryptogenic multifocal ulcerous stenosing enteritis(CMUSE),and to improve the diagnosis of this rare disease.Methods From 2010 to 2015,clinical data of 10 patients with CMUSE were retrospectively analyzed,including clinical features,laboratory examination,imaging examination,appearance under endoscopy,pathologic characteristics,location of lesions,treatment and prognosis.Results Among the 10 patients with CMUSE (male six,female four),the mean age was (35.1±14.8) years.The predominant clinical manifestation was melena (eight cases),abdominal pain (eight cases) and anemia (nine cases).The results of laboratory examination showed normal in erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).Among seven patients,hypersensitive C reactive protein (hsCRP) of two patients increased.Imaging examination showed intestinal stricture and appearance under endoscopic examination was intestinal ulcers and stenosis.Pathologic finding was superficial ulcers at mucosal and submucosal layers.Lesions mostly involved small intestine,and one case involving ileocecal valves and rectum.Among the 10 patients,seven patients received combination of surgical resection and prednisone treatment,and three patients were only administrated with medications.After treatment,seven patients remainedremission and three patients relapsed after remission.Immunosuppressors and enteral nutrition was effective in two of them and glucocorticoid resistance happened in one patient.Conclusions The diagnosis of CMUSE should he considered in patients with unexplained recurrent bowel obstruction,melena,anemia and concomitant intestinal ulcer and stricture.Endoscopy plays an important role in the diagnosis.Glueocorticoid is effective but easy to relapse.Immunomodulators and enteral nutrition may be considered as second-line therapy.
10.iASPP-SV, as an oncogene, participates in breast tumorigenesis and progression
Yinan DONG ; Fanming KONG ; Xinwei ZHANG ; Feng WEI ; Qian SUN
China Oncology 2016;26(10):831-839
Background and purpose:Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is one of the ASPP family. It binds to p53 to inhibit the transcriptional activity of p53-target genes and cell apoptosis, which is asso-ciated with tumor formation. Previously, we found a new subtype of iASPP, iASPP splice variant (iASPP-SV), which is a nuclear protein containing 407 amino acid residues and can bind to p53, inhibiting p53 transcriptional activity. However, the relationship of iASPP-SV and breast cancer is still obscure. Therefore, the purpose of this research was to study the role of iASPP-SV on breast cancer tumorigenesis and progression.Methods:5’-rapid ampliifcation of cDNA ends (RACE) was used to identify the 5’-end of iASPP-SV mRNA in MCF-7 cells. HEK 293 cells were transfected with pFLAG-iASPP-SV and pFLAG-iASPP (828). Then Western blot was used to identify whether endogenous iASPP-SV was expressed in HEK 293 cells and 8 types of human tumor cell lines. This study established the stable clones of NIH 3T3 expressing FLAG-iASPP-SV and FLAG-iASPP (828). Cell proliferation assay, colony formation and soft agar colony formation assay were used to identify whether iASPP-SV and iASPP (828) can promote cell proliferation and iASPP-SV is an oncogene. Real-time lfuorescent quantitative polymerase chain reactive (RTFQ-PCR) was used to de-tect the levels of iASPP-SV and iASPP (828) mRNA in primary breast cancers. Luciferase assays were used to identify the relationships between iASPP-SV, iASPP (828), p53 and NF-κB p65.Results:The study identiifed that iASPP-SV was encoded by previously reported NF-κB p65 subunit (RelA)-associated inhibitor (RAI), and endogenously expressed in many human cancer cell lines. Analysis of cell proliferation, colony formation assay and soft agar assay for colony formation identiifed that similarly to iASPP (828), iASPP-SV promoted tumor cell proliferation and acted as an onco-gene. RTFQ-PCR result showed that the median values of iASPP-SV and iASPP (828) in breast cancers with wild-type p53 were more signiifcantly over-expressed than those of mutant p53. Luciferase assays showed that iASPP-SV and iASPP (828) could suppress NF-κB p65 transcriptional activity. Thus iASPP family may participate in the regulation of p53 and NF-κB activity, which imply that iASPP perhaps shows pro- or anti-survival activities when it interacts with different proteins.Conclusion:These ifndings indicate that iASPP-SV may be a potential target for breast cancer thera-py.